Newsletter | February 5, 2025

02.05.25 -- An Outsourcing Vibe At JP Morgan 25

SPONSOR

Webinar: De-Risking Early Phase Micronization with Integrated Solid Form Selection 

Jet milling is a well-established technology used to micronize APIs for respiratory delivery. Careful selection of the API solid form, whether salt, cocrystal or solvate, is crucial for successful micronization if the desired particle size is to be achieved in a high yield. Learn how to identify viable salt/cocrystal forms for micronization feasibility and enhancing solubility. Click here to learn more.

FEATURED EDITORIAL

An Outsourcing Vibe At JP Morgan 25

The JP Morgan Healthcare conference has never been a venue for directed discussion on outsourcing. That’s not to say such discussions aren’t held. This year, Kurt Nielsen co-hosted an evening devoted to the topic. Nielsen, a veteran outsourcing-industry executive, shares his initial thoughts on the vibe this year.

Survey Findings: How Are IDMP Readiness Efforts Progressing?

ISO Identification of Medicinal Products (IDMP) standards were designed to harmonize the way the life sciences industry records and manages data about its products. Companies’ state of readiness to implement and harness IDMP still varies.

INDUSTRY INSIGHTS

Optimizing Tablets For Even Splitting: The Pressure Sensitive Bisect Design

The pressure-sensitive bisect design allows accurate tablet splitting by maximizing facet width, optimizing angles, and balancing radius values for durability and user-friendly administration.

Accelerated Development Of Solid Oral Dosage Formulation For IND Submission

This paper highlights how the roller compaction process not only enhances efficiency but also improves the scalability of solid oral dosage production, supporting rapid development for regulatory approval.

Utilizing Nanoparticle Technologies For A More Sustainable Value Chain

The pharma industry is identifying ways to make processes more sustainable. Learn how nanoparticle engineering technology can both empower sustainability goals and lead to better patient outcomes.

Achieving Desired Particle Size And Yield Through Efficient Micronization

Here, experts examine how the right combination of advanced technology and specialized expertise can leverage micronization to address the challenges often faced by small molecule drugs.

New Technologies To Improve Solubility Of Brick Dust Compounds

David Lyon, Ph.D., and Molly Adam answer attendee questions from a recent webinar about three enabling technologies designed to improve drug solubility in organic solvents for spray drying.

The Evolution Of A CDMO

Transitioning from a product-based to a service-based organization helped a leading CDMO commit to client-centricity and operational excellence and meet the evolving needs of the pharmaceutical industry.

SOLUTIONS

Comprehensive Regulatory Support

Review our expertise across a wide range of global markets. Our experience in securing regulatory approvals and navigating market challenges positions us as a trusted partner.

Drug Substance Or API Manufacturing

We have an innovative business model that does not add additional costs to your project. Take a look at our network's API capabilities and contact us to simplify your outsourcing solutions.

Environmentally Controlled Stability Storage And Testing Solutions

Cambrex and Q1 Scientific provide stability storage and sample management for the Pharmaceutical, Medical Device, and Life Sciences industries across North America and Europe.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: